18:53 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "GL CHEMTEC INTERNATIONAL LIMITED" found in our extensive news archives from over 250 global news sources.

More Information about GL CHEMTEC INTERNATIONAL LIMITED on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about GL CHEMTEC INTERNATIONAL LIMITED for you to read. Along with our medical data and news we also list GL CHEMTEC INTERNATIONAL LIMITED Clinical Trials, which are updated daily. BioPortfolio also has a large database of GL CHEMTEC INTERNATIONAL LIMITED Companies for you to search.

Showing "CHEMTEC INTERNATIONAL LIMITED" News Articles 476–500 of 5,300+

Monday 4th March 2019

ASHA: New Global Recommendations for Safe Listening Are “An Unprecedented And Significant Step In The Right Direction”

ROCKVILLE, Md. (PRWEB) March 04, 2019 With a worldwide hearing loss risk from unsafe use of personal audio devices going largely unmitigated, for the first time global recommendations exist for reducing the risk—courtesy of the World Health Organization (WHO) and the International Telecommuni...

#Cannabisstocks: SOL Global (CSE: SOL) (OTCQB: SOLCF) Provides Update on Groundbreaking Achievement Made by Its European Strategic Investment European Cannabis Holdings

TORONTO - March 4, 2019 ( Newswire) SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) is pleased to provide an update on the operations of one of its significant international investments, European Cannabis Holdings ("ECH").

Sunday 3rd March 2019

ISEA Launches Industry-Wide Guidelines to Improve Hand Impact Injury

ARLINGTON, Va. (PRWEB) March 04, 2019 The International Safety Equipment Association (ISEA) released a new standard — ANSI/ISEA 138-2019, American National Standard for Performance and Classification for Impact Resistant Hand Protection — to improve on the impact performance of industrial glo...

Avita Medical Announces Collaboration with COSMOTEC, an M3 Group Company, to Commercialize the RECELL® System in Japan

COSMOTEC has filed a JPMDA application for approval to market the RECELL System in Japan AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that it has collaborated with COSMOTEC, an M3 Group company, to market and distribute the RECELL® Autologous Cell Harvesting Device (RECELL® System) for the treatment of bur...

How new species arise in the sea

(Helmholtz Centre for Ocean Research Kiel (GEOMAR)) How can a species split into several new species if they still live close to each other and are able to interbreed? Using a group of Caribbean reef fishes as a model system, a team of scientists from the GEOMAR Helmholtz Centre for Ocean Research Kiel and the Smithsonian Tropical Research Institute has found that natural selection can couple the ...

Young people at risk of addiction have differences in key brain region

(University of Cambridge) Young adults at risk of developing problems with addiction show key differences in an important region of the brain, according to an international team led by researchers at the University of Cambridge.

EASL -- media invitation for ILC 2019

(European Association for the Study of the Liver) The International Liver Congress™ 2019 will take place from 10-14 April 2019. EASL welcomes the interest of the media in matters relating to hepatology and is happy to provide assistance to journalists who wish to attend ILC 2019.

Sacrificing the climate for reelections

(University of Chicago Press Journals) In business as well as international politics, the best and ideal agreement is one that is credible and expected to be complied with. Compliance often necessitates trade sanctions or other sufficiently severe consequences for those parties that do not comply as promised.

International Stem Cell Corporation Commences Trading on the OTCQX Best Market

CARLSBAD, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQX:ISCO) ( ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that it has been approved to trade on the OTCQX Best Market in the United States. International ...

India's stubble burning air pollution causes USD 30 billion economic losses, health risks

(International Food Policy Research Institute) India's air pollution made headlines around the globe last year. IFPRI researchers estimate the economic and health cost of air pollution caused due to stubble burning at USD 30 billion per year in a new research -- the first to arrive at these estimates.

UN declares decade of ecosystem restoration

(Society for Ecological Restoration International) The United Nations today recognized the critical role of ecosystem restoration as a tool for improving environmental conditions and enhancing human communities by designating 2021-2030 the UN Decade on Ecosystem Restoration. This global recognition comes after growing calls and commitments by the international community to put ecological restorati...

AVITA Medical Announces Temporary Interruption of Sales of Products in EU

-Sales temporarily interrupted while closing administrative and procedural open items related to EU certificates and unrelated to product performance -No impact on U.S. market AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that sales of the RECELL® Device in the EU have been temporarily ...

Global Medical Sample Collection Tubes Market Data Survey Report 2025 [Report Updated: 01011970] Prices from USD $1500

SummaryThe global Medical Sample Collection Tubes market will reach Volume Million USD in 2018 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers manufacturing sites, capacity and production, product specifications etc.Major ApplicationMajor TypeKey manufacturers are included bas...

Saturday 2nd March 2019

TATOUAGES : Sont-ils un marqueur de mode de vie et de santé ?

Les tatouages ​​sont-ils liés à la santé des personnes, sont-ils un marqueur de comportements à risque, se sont interrogés ces chercheurs de de l'Université de Miami. Eh bien, pas vraiment ou pas tout à fait, conclut cette enquête à paraître dans l’International Journal of Dermatology et dont nous livrons ici les résultats préliminaires. De précédentes […]

ANLEIHEN-Woche KW9 - 2019: R-LOGITECH, Katjes International, PNE, Dt. Mittelstandsanleihen FONDS, PCC, gamigo, Mologen, Exporo,…

Die Woche vom 25.02. bis 01.03.2019 (KW9) steht am KMU-Anleihen-Markt im Zeichen der angekündigten 100 Mio. Euro-Aufstockung der 8,50%-R-LOGITECH-Anleihe. Die Unternehmensanleihe 2018/23 (ISIN: DE...

Friday 1st March 2019

PanTheryx Presents Positive Results from Two New DiaResQ Studies at its 2019 International Scientific Symposium

New clinical data and case studies highlight the use of DiaResQ in a range of real world settings, from hospitals to disaster relief, in its first annual scientific meeting PanTheryx, a biotechnology company committed to realizing the potential of novel interventions to address a wide range of serious GI microbiome related health conditions, announced ...

[Comment] Will dual Japanese encephalitis and measles-rubella vaccination hinder measles and rubella eradication?

In The Lancet Infectious Diseases, Yan Li and colleagues1 present a multicentre randomised controlled trial to assess whether live-attenuated Japanese encephalitis vaccine (LJEV) impairs measles and rubella antibody responses to coadministered measles-rubella vaccine. China's National Immunisation Programme has recommended dual LJEV and measles-rubella vaccination at 8 months of age since 2008 but...

Endo gains on favorable FDA drug compounding decision

Endo International Plc said on Friday the U.S. health regulator has decided not to include blood pressure treatment vasopressin in its list of drugs that can be used in compounding, in a boost to the drugmaker that makes the on...

Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List

DUBLIN, March 1, 2019 /PRNewswire/ -- Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.S. Food and Drug Administration (FDA) has determined that there is no clinical need ...

DGAP-News: Chemesis International Inc.: Chemesis International Inc. meldet Abschluss einer Privatplatzierung in Höhe von 2.760.000 Dollar und Abkommen für eine Aktienzeichnungsfazilität in Höhe von 10.000.000 Dollar (deutsch)

Chemesis International Inc.: Chemesis International Inc. meldet Abschluss einer Privatplatzierung in Höhe von 2.760.000 Dollar und Abkommen für eine Aktienzeichnungsfazilität in Höhe von 10.000.000...

EMA Panel Backs Zanamivir IV for Complicated, Severe Influenza

The EMA's Committee for Medicinal Products for Human Use recommended marketing authorization under exceptional circumstances for zanamivir for complicated and potentially life-threatening influenza. International Approvals

EU Panel OKs Sotagliflozin for Some With Type 1 Diabetes

The decision includes a list of requirements for use of the SGLT1/ SGLT2 inhibitor in select patients to minimize DKA risk. The EU approval will be the first worldwide for sotagliflozin. International Approvals

Global Perspective Newsletter for February 2019

The February 2019 edition of our Global Perspective Newsletter is now available. Read the latest news from ADI, our partners and member associations, including updates from the WHO Executive Board; the Korean National Institute (KNID)'s symposium; Dementia Alliance International, and much more. [read it now]

EU Panel Backs Risankizumab (Skyrizi) for Plaque Psoriasis

The interleukin-23 inhibitor is for treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. International Approvals

Morgan Stanley Executive Director Joins Vinzan International

Today, Vinzan International Inc., a Toronto-based cannabis trading company, is pleased to announce the appointment of Donald Stewart as Chief Financial Officer. Donald brings 20 years of leadership experience in capital markets to Vinzan International as they prepare for their 2019 initial public offering. Donald comes to Vinzan International after nearly ...

Quick Search


News Quicklinks